references
- Macintosh MCM, Acolet D, Bailey JA, . Perinatal mortality and congenital abnormalities in babies of women with type 1 or type 2 diabetes in England, Wales and Northern Ireland: Population based study. BMJ 2006;333:177–82.
- CEMACH. Diabetes in pregnancy: Are we providing the best care?Findings of a national enquiry – England, Wales and Northern Ireland. London: CEMACH 2007.
- Holing EV, Beyer CS, Brown ZA, . Why don't women with diabetes plan their pregnancies. Diabetes Care 1998;21:889–95.
- Vahratian A, Barber JS, Lawrence JM, . Family-planning practices among women with diabetes and overweight and obese women in the 2002 National Survey For Family Growth. Diabetes Care 2009;32:1026–31.
- Varughese G, Chowdhury S, Warner D, . Preconception care of women attending adult general diabetes clinics: Are we doing enough? Diabetes Res Clin Pract 2007;76:142–5.
- Burawoy M. The extended case method. Sociol Theory 1998;16:4–33. Accessed 25 May 2011 from: http://cue.berkeley.edu/publications.html
- General Practice Research Database. Accessed 12 November 2010 from: http://www.gprd.com
- Shawe J, Mulnier H, Nicholls P, . Use of hormonal contraceptive methods by women with diabetes Primary Care Diabetes 2008;2:195–9.
- SPSS 12.00 for Windows Chicago IL 2003.
- NVIVO 7 Qualitative data analysis program. Accessed 25 May 2011 from: http://www.qrsinternational.com/
- Lader D. Contraception and sexual health2006/07. London: Office for National Statistics 2007.
- Vessey MP, McPherson K, Johnson B. Mortality among women participating in the Oxford Family Planning Association Contraceptive Study. Lancet 1977;2:731–7.
- Gibb D, Brown LJ, Hockey S, . Attitudes and knowledge regarding contraception and pre-pregnancy counselling in insulin dependent diabetes. NZ Med J 1994;107:484–6.
- Girling J, de Swiet M. Contraception for women with diabetes or hypertension. Trends Urol Gynaecol Sex Health 1997;2:23–33.
- Swerdlow AJ, Jones ME. Mortality during 25 years of follow-up of a cohort with diabetes. Int J Epidemiol 1996;25:1250–61.
- FFPRHC UK. Medical eligibility criteria for contraceptive use. Faculty of Family Planning and Reproductive Health Care 2009. Accessed 25 May 2011 from: http://www.ffprhc.org.uk/
- Shawe JA, Lawrenson RA. Hormonal contraception in women with diabetes mellitus. Treat Endocrinol 2003;2:321–30.
- Mestman J H, Schmidt Sarosi C. Diabetes mellitus and fertility control: Contraception management issues. Am J Obstet Gynecol 1993;168:2012–20.
- Joint Formulary Committee. British national formulary 59. London : British Medical Association and Royal Pharmaceutical Society 2010.
- Diab KM, Zaki MM. Contraception in diabetic women: Comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A. J Obstet Gynaecol Res 2000;26: 7–26.
- Sorenson M.B, Collins P, Ong PJ, . Long term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation 2002;106:1646–51.
- WHO. Medical eligibility criteria for contraceptive use, 4th. Geneva: WHO 2009. Accessed 26 April 2011 from: http://www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/index.html.
- Department of Health. National Service framework for diabetes. London: HMSO 2001.
- Haboubi NH, Lincoln N. Views of health professionals on discussing sexual issues with patients. Disabil Rehabil 2003;6:291–6.
- Stokes T, Mears J. Sexual health and the practice nurse: A survey of reported practice and attitudes. Br J Fam Plann 2000;26:89–92.
- Avery L, Lazdane G. What do we know about sexual and reproductive health of adolescents in Europe? Eur J Contracept Reprod Health Care 2008;13:58–70.
- Wellings K, Hart G. Sexual behaviour and its medicalisation: In sickness and in health BMJ 2002;324: 896–900.